Arcoma AB (STO:ARCOMA)

Arcoma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	3.8	5.03	11.18	2.56	1.9	-7.47
Depreciation & Amortization	-0.11	0.23	0.92	1.59	1.66	1.5
Other Amortization	7.12	7.12	7.02	6.5	4.94	4.63
Other Operating Activities	2.02	2.79	1.73	0.81	-0.75	-1.99
Change in Accounts Receivable	6.65	2.2	1.29	8.22	-9.12	6.76
Change in Inventory	5.35	0.31	4.09	0.27	-8.51	4.5
Change in Accounts Payable	-4.6	1.31	-7.22	-1.7	10.9	-6.12
Change in Other Net Operating Assets	1.14	-0.27	-0.15	0.91	-1.19	-3.73
Operating Cash Flow	21.35	18.72	18.84	19.16	-0.18	-1.93
Operating Cash Flow Growth	86.79%	-0.66%	-1.65%	-	-	-
Capital Expenditures	-0.45	-0.22	-	-	-0.01	-0.69
Sale (Purchase) of Intangibles	-4.46	-5.41	-6.78	-2.55	-4.16	-3.5
Investing Cash Flow	-4.91	-5.62	-6.78	-2.55	-4.17	-4.19
Short-Term Debt Issued	-	-	-	-	8.35	-
Long-Term Debt Issued	-	-	-	-	1.5	4.11
Total Debt Issued	-	-	-	-	9.85	4.11
Short-Term Debt Repaid	-	-	-	-18.28	-	-3.05
Long-Term Debt Repaid	-	-	-3.87	-2.94	-1.37	-1.46
Total Debt Repaid	-	-	-3.87	-21.22	-1.37	-4.51
Net Debt Issued (Repaid)	-	-	-3.87	-21.22	8.48	-0.4
Issuance of Common Stock	10.36	10.36	-	-	1.16	2.79
Financing Cash Flow	10.36	10.36	-3.87	-21.22	9.65	2.4
Foreign Exchange Rate Adjustments	-1.07	-1.52	0.19	-0.05	-0.47	-0.03
Net Cash Flow	25.74	21.94	8.38	-4.66	4.83	-3.75
Free Cash Flow	20.91	18.51	18.84	19.16	-0.19	-2.62
Free Cash Flow Growth	82.86%	-1.80%	-1.65%	-	-	-
Free Cash Flow Margin	16.47%	14.15%	12.02%	11.75%	-0.15%	-2.24%
Free Cash Flow Per Share	1.43	1.29	1.43	1.45	-0.01	-0.20
Cash Interest Paid	0.12	0.12	0.26	1.39	0.9	0.76
Levered Free Cash Flow	13.48	9.06	7.08	15.3	-3.39	-2.2
Unlevered Free Cash Flow	13.55	9.14	7.24	16.17	-2.83	-1.72
Change in Working Capital	8.53	3.56	-2	7.7	-7.93	1.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.